GRI BIO INC
GRINASDAQEarnings Aug 12US Equity
$339.01▼ $14.20 (−4.19%)
Simulated price1h—
24h▼ 4.2%
7d—
14d—
30d—
1y—
🏦Market Cap
$279.83B
Large Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
48
Weak
No chart data available for GRI.
Trading Snapshot
- Day Range
- $336.94 – $341.86
- 52-Week Range
- —
- Volume
- $3.36B
- Avg Volume
- $2.64B
- Shares Outstanding
- —
- Next Earnings
- Oct 2, 2026
Fundamentals Snapshot
- Annual Revenue
- $133.25B
- Last Q Revenue
- $37.15B
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- —
- Dividend Yield
- —
Why Investors Own GRI
- ✓High-growth profile — revenue up +38.5% YoY with expanding US Equity exposure.
- ✓Healthy economics — 26% gross margin and 24% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$133.25B▲ +42.1% YoY
Gross Margin (TTM)
26.0%▲ +0.7% YoY
Operating Income (TTM)
$29.32B▲ +42.1% YoY
Free Cash Flow (TTM)
$32.38B▲ +42.1% YoY
About GRI BIO INC
A company profile for GRI BIO INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
48/100
Analyst Ratings
ⓘConsensus
Buy
6 analysts
Strong Buy1
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of Aug 2026
Latest News & Updates
Benzinga·13h ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regular session. The market value of their outstanding shares is at $151.0 million. As per the press release, Q2 earnings
Benzinga·22d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market session. The market value of their outstanding shares is at $8.2 million. Barinthus Biotherapeutics (NASDAQ:BRNS) shares